Jula Inrig, CHIEF MEDICAL OFFICER at Travere Therapeutics, Inc. (TVTX), sold 22,485 shares at $45.00 ($1.0M) on 2026-05-04, disclosed to the SEC on 2026-05-06.
Scheduled sale ($1.0M) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.00 | 20,000 | $900K | 88.7% |
| 2 | $46.65 | 2,174 | $101K | 10.0% |
| 3 | $43.95 | 311 | $14K | 1.3% |
| Total | $45.15 avg | 22,485 | $1.0M | 100% |
| Filing → |
| TVTX | SELL | 2026-02-05 | $57K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $223K | — | Filing → |
| TVTX | SELL | 2026-01-07 | $98K | — | Filing → |